U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07485582) titled 'Exploration of Current and New Technologies for Accuracy of Diagnosing OSA' on Feb. 19.
Brief Summary: Resmed is the manufacturer of medical devices which screen, diagnose, treat and monitor people with sleeping and respiratory disorders, such as obstructive sleep apnea (OSA).
From time to time, for regulatory, quality, and marketing purposes, there may be a need to test the various products performance against PSG (gold standard technology), and other products.
The purpose of this study is:
1. Products performance against PSG
2. comparison against other products, and
3. Assessments of potential new technologies
Study Start D...